Scenarios that move FDMT
4D Molecular Therapeutics, Inc. - Common Stock
Scenarios that move FDMT: 3 analyses, 1 positive, 2 negative.
- · Roche reports positive Phase III eye drug data, FDA accepts BLA — ▼ · impact -56 · confidence low · horizon weeks
- · Kodiak Sciences shares soar 178% on positive wet AMD data — ▼ · impact -38 · confidence medium · horizon weeks
- · Sion cuts workforce nearly half after CF study failure — ▲ · impact +25 · confidence low · horizon weeks